- Home
- ATGL vs HLVX Comparison
ATGL vs HLVX Comparison
Compare ATGL & HLVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATGL
- HLVX
- Stock Information
- Founded
- ATGL 2017
- HLVX 2020
- Country
- ATGL Hong Kong
- HLVX United States
- Employees
- ATGL N/A
- HLVX N/A
- Industry
- ATGL
- HLVX Biotechnology: Pharmaceutical Preparations
- Sector
- ATGL
- HLVX Health Care
- Exchange
- ATGL Nasdaq
- HLVX Nasdaq
- Market Cap
- ATGL 89.7M
- HLVX 87.6M
- IPO Year
- ATGL 2023
- HLVX 2022
- Fundamental
- Price
- ATGL $9.71
- HLVX $1.83
- Analyst Decision
- ATGL
- HLVX Hold
- Analyst Count
- ATGL 0
- HLVX 5
- Target Price
- ATGL N/A
- HLVX $2.33
- AVG Volume (30 Days)
- ATGL 189.1K
- HLVX 130.0K
- Earning Date
- ATGL 11-26-2024
- HLVX 11-07-2024
- Dividend Yield
- ATGL N/A
- HLVX N/A
- EPS Growth
- ATGL N/A
- HLVX N/A
- EPS
- ATGL N/A
- HLVX N/A
- Revenue
- ATGL $1,171,763.00
- HLVX N/A
- Revenue This Year
- ATGL N/A
- HLVX N/A
- Revenue Next Year
- ATGL N/A
- HLVX N/A
- P/E Ratio
- ATGL N/A
- HLVX N/A
- Revenue Growth
- ATGL 21.27
- HLVX N/A
- 52 Week Low
- ATGL $1.15
- HLVX $1.55
- 52 Week High
- ATGL $31.39
- HLVX $20.22
- Technical
- Relative Strength Index (RSI)
- ATGL 59.81
- HLVX 44.81
- Support Level
- ATGL $8.71
- HLVX $1.80
- Resistance Level
- ATGL $10.36
- HLVX $2.02
- Average True Range (ATR)
- ATGL 1.57
- HLVX 0.08
- MACD
- ATGL -0.18
- HLVX -0.00
- Stochastic Oscillator
- ATGL 46.10
- HLVX 13.95
About ATGL Alpha Technology Group Limited
Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.
About HLVX HilleVax Inc.
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.